Myrobalan Therapeutics
2025年3月13日 · We strive to develop first-in-class and best-in-class oral small molecule therapies for those suffering from CNS diseases. Successful CNS drugs demand a wide …
Myrobalan - Wikipedia
The common name myrobalan can refer to several unrelated fruit-bearing plant species: Myrobalan plum (Prunus cerasifera), also called cherry plum and myrobalan plum; Emblic …
Myrobalan facts and health benefits
2018年12月30日 · Myrobalan or Haritaki scientifically known as Terminalia Cebula is a typical Indian herb belonging to the plant family Combretaceae (Indian almond family). Indian …
Myrobalan wins grant for MS remyelination candidate MRO-002
2025年3月18日 · Myrobalan Therapeutics has been awarded a grant of more than $850,000 from the National Multiple Sclerosis Society to advance its new oral candidate MRO-002 for treating …
新锐！迈巴制药完成2400万美元A轮融资，两名美国华人院士共同 …
2024年1月11日 · 迈巴制药致力于开发口服神经修复疗法，包括针对促进髓鞘再生的重要靶点G-蛋白偶联受体17（GPR17）的拮抗剂；靶向参与脱髓鞘和神经炎症的集落刺激因子-1受 …
About - Myrobalan Therapeutics
Myrobalan Therapeutics is a CNS-focused pre-clinical biotech company developing medicines to address the unmet need and societal burdens of neurodegenerative and demyelinating …
Terminalia chebula - Wikipedia
Terminalia chebula, commonly known as black- or chebulic myrobalan, [3] is a species of Terminalia, native to South Asia from Pakistan, India and Nepal east to southwest China …
Myrobalan Therapeutics – TYK2
Myrobalan’s brain-penetrant allosteric TYK2 inhibitor demonstrates robust suppression of inflammatory cascades with minimal off-target effects. Preliminary data reveal superior …
迈巴制药（Myrobalan Therapeutics）完成2400万美元A轮融资， …
2024年1月11日 · 迈巴制药致力于开发口服神经修复疗法，包括针对促进髓鞘再生的重要靶点G-蛋白偶联受体17（GPR17）的拮抗剂；靶向参与脱髓鞘和神经炎症的集落刺激因子-1受 …
Myrobalan Therapeutics, Inc. (Myrobalan Therapeutics, Inc.) - 药 …
Myrobalan applies deep knowledge of neurological processes such as demyelination and neuroinflammation, and innovative drug discovery tools, to create highly selective and brain …